Who invested in i2o Therapeutics?
i2o Therapeutics's investors include Sanofi.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$46Mraised across 1 round since 2023, from 1 source
From the SEC filings it signed: 1 on the team.
On the board, as filediAnthony AiudiChristopher Gagliardi
i2o Therapeutics's investors include Sanofi.
i2o Therapeutics has raised $46M across 1 round since 2023.
i2o Therapeutics's most recent round was a Series A of $46M in Aug 2023.
Its most recent round, $46M in Aug 2023, is also its largest on record.
i2o Therapeutics's first round on record, in Aug 2023, was backed by Sanofi.
i2o Therapeutics's latest named round is a Series A, in Aug 2023.
i2o Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.